Practice Competition and Treatment of Newly Diagnosed Prostate Cancer.

[1]  M. Furukawa,et al.  Consolidation Of Providers Into Health Systems Increased Substantially, 2016-18. , 2020, Health affairs.

[2]  G. Deeb,et al.  The Effect of Hospital Market Competition on the Adoption of Transcatheter Aortic Valve Replacement. , 2020, The Annals of thoracic surgery.

[3]  Leemore S. Dafny,et al.  Changes in Quality of Care after Hospital Mergers and Acquisitions. , 2020, The New England journal of medicine.

[4]  T. Skolarus,et al.  Practice-Level Adoption of Conservative Management for Prostate Cancer. , 2019, Journal of oncology practice.

[5]  J. Mohler,et al.  NCCN Guidelines Updates: Management of Prostate Cancer. , 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

[6]  Andrew S. Boozary,et al.  The Association Between Hospital Concentration And Insurance Premiums In ACA Marketplaces. , 2019, Health affairs.

[7]  J. Van Reenen,et al.  THE PRICE AIN'T RIGHT? HOSPITAL PRICES AND HEALTH SPENDING ON THE PRIVATELY INSURED. , 2018, The quarterly journal of economics.

[8]  David C. Miller,et al.  Variation in prostate cancer treatment and spending among Medicare shared savings program accountable care organizations , 2018, Cancer.

[9]  Ronald C. Chen,et al.  Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part II: Recommended Approaches and Details of Specific Care Options , 2018, The Journal of urology.

[10]  David C. Miller,et al.  Early effect of Medicare Shared Savings Program accountable care organization participation on prostate cancer care , 2018, Cancer.

[11]  T. Skolarus,et al.  Urologist Practice Affiliation and Intensity-modulated Radiation Therapy for Prostate Cancer in the Elderly. , 2017, European urology.

[12]  A. Mehrotra,et al.  High-Price And Low-Price Physician Practices Do Not Differ Significantly On Care Quality Or Efficiency. , 2017, Health affairs.

[13]  David Gillatt,et al.  10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer. , 2017, The New England journal of medicine.

[14]  Issa J Dahabreh,et al.  Using group data to treat individuals: understanding heterogeneous treatment effects in the age of precision medicine and patient-centred evidence. , 2016, International journal of epidemiology.

[15]  D. Muhlestein,et al.  Physician Consolidation: Rapid Movement From Small To Large Group Practices, 2013-15. , 2016, Health affairs.

[16]  S. Parente,et al.  Prices For Common Medical Services Vary Substantially Among The Commercially Insured. , 2016, Health affairs.

[17]  L. Baker,et al.  Physician practice competition and prices paid by private insurers for office visits. , 2014, JAMA.

[18]  T. Tammela,et al.  Overdiagnosis and overtreatment of prostate cancer. , 2014, European Urology.

[19]  Abe Dunn,et al.  Do Physicians Possess Market Power? , 2014, The Journal of Law and Economics.

[20]  D. Contandriopoulos,et al.  Fee increases and target income hypothesis: data from Quebec on physicians' compensation and service volumes. , 2013, Healthcare Policy | Politiques de Santé.

[21]  David M Cutler,et al.  Hospitals, market share, and consolidation. , 2013, JAMA.

[22]  John T. Wei,et al.  Use of advanced treatment technologies among men at low risk of dying from prostate cancer. , 2013, JAMA.

[23]  Y. Kuo,et al.  Reimbursement policy and androgen-deprivation therapy for prostate cancer. , 2010, The New England journal of medicine.

[24]  M. Tinetti,et al.  The Effect of Age and Chronic Illness on Life Expectancy after a Diagnosis of Colorectal Cancer: Implications for Screening , 2006, Annals of Internal Medicine.

[25]  M. Gaynor,et al.  Increasing consolidation in healthcare markets: what are the antitrust policy implications? , 1998, Health services research.

[26]  M. Chernew,et al.  Market Share Matters: Evidence Of Insurer And Provider Bargaining Over Prices. , 2017, Health affairs.